产品名称:Rozanolixizumab
中文名称:洛利昔珠单抗
产品别称:UCB-7665, rozanolixizumab-noli
靶点:FcRn [Homo sapiens]
抗体亚型:IgG4 Kappa
来源:CHO Cells
体内实验:在FcRn转基因小鼠模型中,Rozanolixizumab剂量依赖性和选择性地降低血浆IgG浓度[1]。
参考文献:1.Smith B, Kiessling A, Lledo-Garcia R, et al. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration. MAbs. 2018;10(7):1111-1130. doi:10.1080/19420862.2018.1505464
仅供科研使用